23andMe | Investor Presentation Deck | 57 slides · page 44 of 57
Data shows 23ME '610 consistently outperforms isotype control and anti-PD1 in IFNy production across most tested cancer types.
Pitch deck · solution · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 paragraph 2/2 title 2/2
Components 5
bar-grouped paragraph paragraph action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.